Evaluation of the Short-Form 36-Item Questionnaire to Measure Health- Related Quality of Life in Patients With Idiopathic Pulmonary Fibrosis*
نویسندگان
چکیده
Objective: To validate the use of the 36-item short-form questionnaire (SF-36) for measuring health-related quality of life (HRQL) in patients with idiopathic pulmonary fibrosis (IPF). Design: Observational data at a single point in time. Setting: A specialized outpatient respiratory clinic. Participants: Thirty-four patients (mean 6 SE age, 58.29 6 1.87 years) with IPF and no significant comorbidity. A matched control group for HRQL measurements was composed of 34 normal subjects (mean age, 58.00 6 1.89 years). Measurements and results: Dyspnea was measured by the baseline dyspnea index (BDI). Respiratory function evaluation included FVC, FEV1, and resting arterial blood gases. IPF patients showed a mean BDI score of 5.21 6 0.46. The mean FVC and FEV1 values were 62.41 6 2.96% and 66.41 6 3.33%, respectively. The mean PaO2 was 67 6 2.51 mm Hg, and the mean PaCO2 was 37 6 1.05 mm Hg. Patients scored significantly worse than control subjects with respect to the SF-36 domains of physical functioning, physical role, general health perceptions, vitality, social functioning, emotional role, and mental health index. BDI scores were significantly correlated with five SF-36 components, and FVC and FEV1 were significantly correlated with two SF-36 components. Significant negative correlations were found between arterial pH and four SF-36 domains. Conclusions: Patients with IPF have a significant impairment of HRQL in both physical and psychological functioning. Dyspnea is the most important factor influencing the quality of life in these subjects. The SF-36 questionnaire is a valid instrument to evaluate HRQL in IPF patients. (CHEST 2000; 117:1627–1632)
منابع مشابه
Pulmonary Rehabilitation in Idiopathic Pulmonary Fibrosis: A Chance for a Multidisciplinary Treatment Approach
Background and Objectives: Idiopathic pulmonary fibrosis (IPF) is characterized by progressively worsening lung function, ventilation capacity, dyspnea, and finally reduced exercise intolerance. All of these have a significant negative impact on functional capacity and quality of life. In this study, we aim to evaluate the effects of pulmonary rehabilitation (PR) in IPF and assess the predictor...
متن کاملEffects of inpatient pulmonary rehabilitation in patients with interstitial lung disease.
Pulmonary rehabilitation is recommended for patients with chronic lung diseases including idiopathic pulmonary fibrosis according to international guidelines. However, data for patients with interstitial lung disease (ILD) are limited. We examined the effect of an inpatient pulmonary rehabilitation on functional status and quality of life in ILD patients. We evaluated 402 consecutive ILD patien...
متن کاملThe Assessment of Reliability and Validity of Persian Version of the Endometriosis Health Profile (EHP-30)
Background: The Endometriosis Health Profile-30 (EHP-30) is a disease-specific questionnaire to measure the health-related quality of life in patients with endometriosis. The aim of this study was to evaluate the validity and reliability of the Persian version of Endometriosis Health Pro-file (EHP-30) in women with endometriosis referring to three Gynecology Clinics in Tehran, Iran. Met...
متن کاملQuality of life and health-related quality of life in hepatitis C patients and B patients
Background: Psychosocial issues and quality of life are important components at the patients diagnosed with chronic hepatitis B and C. Hepatitis is a chronic liver disease that can affect quality of life of patients. In this study, we compared the quality of life between patients with hepatitis B and C and finally presented a structural model about it. Methods: In a prospective analytic study,...
متن کاملQuality of life and dyspnoea in patients treated with bosentan for idiopathic pulmonary fibrosis (BUILD-1).
No therapy is known to improve health-related quality of life (HRQoL) or dyspnoea in patients with idiopathic pulmonary fibrosis. The present study investigated longitudinal changes in HRQoL and dyspnoea and explored the effects of bosentan on these end-points during the Bosentan Use in Interstitial Lung Disease (BUILD)-1 trial. In total, 154 subjects received oral bosentan (n = 71) or placebo ...
متن کامل